GB0511003D0 - Screening and treatment of alzheimer's disease - Google Patents

Screening and treatment of alzheimer's disease

Info

Publication number
GB0511003D0
GB0511003D0 GB0511003A GB0511003A GB0511003D0 GB 0511003 D0 GB0511003 D0 GB 0511003D0 GB 0511003 A GB0511003 A GB 0511003A GB 0511003 A GB0511003 A GB 0511003A GB 0511003 D0 GB0511003 D0 GB 0511003D0
Authority
GB
United Kingdom
Prior art keywords
alzheimer
screening
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0511003A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cardiff Consultants Ltd
Cardiff University
Original Assignee
University College Cardiff Consultants Ltd
Cardiff University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cardiff Consultants Ltd, Cardiff University filed Critical University College Cardiff Consultants Ltd
Priority to GB0511003A priority Critical patent/GB0511003D0/en
Publication of GB0511003D0 publication Critical patent/GB0511003D0/en
Priority to PCT/GB2006/001850 priority patent/WO2006129058A2/en
Ceased legal-status Critical Current

Links

GB0511003A 2005-05-28 2005-05-28 Screening and treatment of alzheimer's disease Ceased GB0511003D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0511003A GB0511003D0 (en) 2005-05-28 2005-05-28 Screening and treatment of alzheimer's disease
PCT/GB2006/001850 WO2006129058A2 (en) 2005-05-28 2006-05-19 Screening and treatment of alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0511003A GB0511003D0 (en) 2005-05-28 2005-05-28 Screening and treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
GB0511003D0 true GB0511003D0 (en) 2005-07-06

Family

ID=34834847

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0511003A Ceased GB0511003D0 (en) 2005-05-28 2005-05-28 Screening and treatment of alzheimer's disease

Country Status (2)

Country Link
GB (1) GB0511003D0 (en)
WO (1) WO2006129058A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160051527A1 (en) * 2013-01-22 2016-02-25 Courtagen Life Sciences, Inc. Methods and kits for treating and classifying individuals at risk of or suffering from a neurological dysfunction or disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518329A (en) * 1998-06-16 2002-06-25 イーライ・リリー・アンド・カンパニー How to increase acetylcholine levels

Also Published As

Publication number Publication date
WO2006129058A2 (en) 2006-12-07
WO2006129058A3 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
EP1951892A4 (en) Antibody treatment of alzheimer's and related diseases
EP1817050A4 (en) Diagnosis and treatment of alzheimer's disease
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
HUS1500043I1 (en) Methods for treatment of parkinson's disease
EP2001503A4 (en) Diagnosis and treatment of alzheimer's disease
ES2414872T8 (en) Combined therapy for the prevention or treatment of Alzheimer's disease and corresponding kit
EP1910829A4 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
IL185052A0 (en) Treatment of bone disorders
AU2003220096A8 (en) Methods for alzheimer's disease treatment and cognitive enhancement
EP1711191A4 (en) Chlorite in the treatment of neurodegenerative disease
PL2104682T3 (en) Diagnosis and treatment of alzheimer's and other neurodementing diseases
EP1928453A4 (en) Methods and compositions for the preventioin and treatment of kidney disease
IL178815A0 (en) The treatment of respiratory disease
EP2091566A4 (en) Combination treatments for alzheimer's disease and similar diseases
ZA200607471B (en) Materials and methods for treatment of allergic disease
GB0410399D0 (en) The treatment of respiratory disease
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
EP1954800A4 (en) Composition and use of phyto-percolate for treatment of disease
GB0320238D0 (en) Treatment of disease
EP1773882A4 (en) Diagnosis and treatment of siglec-6 associated diseases
EP1928247A4 (en) Composition and use of phyto-percolate for treatment of disease
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
EP1924286A4 (en) Phrophylactic and/or therapeutic method for treatment of autoimmune disease
GB0414894D0 (en) Biomarkers of alzheimer's disease
IL188318A0 (en) Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)